José Fabián Martínez-Herrera

5PUBLICATIONS
17CO-AUTHORS
Cancer diagnosisCardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 06, 2024
Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico.

Denisse Añorve Bailon, Javier Picó-Guzmán, Sergio Cifuentes

|Jan 23, 2024
Correction: Arce-Huamani et al. Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Medicina 2023, 59, 1867.

Miguel A Arce-Huamani, Joshuan J Barboza, José Fabián Martínez-Herrera

|Oct 28, 2023
Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Miguel A Arce-Huamani, Joshuan J Barboza, José Fabián Martínez-Herrera

|Mar 11, 2023
Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed Skin.

Saraí G De Leon-Rodríguez, Cristina Aguilar-Flores, Julián A Gajón

|Aug 19, 2021
A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.

Jerónimo Rafael Rodríguez-Cid, Sonia Carrasco-Cara Chards, Iván Romarico González-Espinoza

Pageof 1

Frequent Collaborators

2 joint publications

Jeronimo Rodríguez Cid

2 joint publications

Miguel A Arce-Huamani

2 joint publications

Jorge L Maguiña

1 joint publications

Rodrigo Riera-Sala